ACELRX PHARMACEUTICALS INC - COM (ACRX)

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
18,372,846
Share change
-2,843,192
Total reported value
$77,900,192
Put/Call ratio
105%
Price per share
$4.24
Number of holders
61
Value change
-$11,704,132
Number of buys
24
Number of sells
45

Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q2 2015

As of 30 Jun 2015, ACELRX PHARMACEUTICALS INC - COM (ACRX) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,372,846 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Palo Alto Investors, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, VANGUARD GROUP INC, FMR LLC, Cormorant Asset Management, LLC, SENZAR ASSET MANAGEMENT, LLC, BlackRock Fund Advisors, MORGAN STANLEY, and UNITED SERVICES AUTOMOBILE ASSOCIATION. This page lists 61 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.